Aktiesnakken — Juli 2010
-
SÅ
-
GlaxoSmithKline og Genmab offentliggør ændring i ofatumumabaftalen
-
Genmab vil modtage en upfrontbetaling på GBP 90 mio. (DKK 815 mio.) fra GSK.
-
-
den ser sgu god ud!!!!
-
det må være en køber i aftenhandlen?
-
-
autoimmuneudvikling overgår til gsk, hvorved milestones bortfalder... men roylaty-satasen består
-
hvad siger aftenhadnlen?
-
Køb
-
Den går i 100
-
mon ikke lisas afgang har en relation til denne aftale????
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind